Gilead traders had something to celebrate on Tuesday. The company’s HIV drug has met its goal in four late-stage studies The company made the announcement on Tuesday that a combination of this experimental HIV drug bictegravi along with already existing therapies have met the goal in four late stage studies. Gilead evaluated the addition of … Continue reading “Gilead Shares Climb Higher After Impressive HIV Drug News”
